Animal & Veterinary
CVM Seeks Comments On Draft Risk Assessment By February 10
January 6, 2000
In conjunction with the Center for Veterinary Medicine's (CVM's) December 9-10, 1999, workshop on antimicrobial resistance in food-producing animals, the Center released a draft "Risk Assessment on the Human Health Impact of Fluoroquinolone Resistant Campylobacter Associated with the Consumption of Chicken." This draft was released on the Center's Home Page on the Internet and at the December workshop. FDA's CVM is seeking comments on this draft risk assessment by February 10, 2000.
The risk assessment was intended to determine the feasibility of estimating risk to human health from resistant foodborne pathogens associated with the use of antimicrobials in food-producing animals. Specifically, a mathematical model was derived to relate the prevalence of fluoroquinolone resistant Campylobacter infections in humans associated with the consumption of chicken to the prevalence of fluoroquinolone resistant Campylobacter in chickens.
This draft risk assessment is on our Home Page. Individuals interested in this document who do not have access to the internet may receive a single copy by calling or writing CVM's Communications Staff at FDA/Center for Veterinary Medicine, HFV-12, 7500 Standish Place, Rockville, MD 20855, 301-594-1755. Send one self-addressed adhesive label to assist in processing your requests.
Interested persons should submit written comments on the draft risk assessment to the Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Comments should be identified with Docket Number 98D-0969. To be considered in CVM's revision of the draft risk assessment, comments should be received by February 10, 2000.